Search
for
Sort by
Research 721–750 of 771
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Modern dermatology brings treatment even for alopecia areata
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Switching between tofacitinib and baricitinib in alopecia areata: A review of clinical response
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Improvement of Psoriasis, Psoriatic Arthritis, and Alopecia Universalis during Treatment with Tofacitinib: A Case Report
- Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata
- Experience with oral tofacitinib in two adolescents and seven adults with alopecia areata
- New Treatments for Hair Loss
- Hair for the Long Haul: Alopecia Areata Cases and Considerations
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
- Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- 013 IL-15/IL-15Rα signaling is a guardian of human hair follicle immune privilege and promotes hair growth
- Baricitinib in the Management of Coexisting Alopecia Areata and Atopic Dermatitis: A Case Report
- Clinical response to oral tofacitinib in pediatric patients with alopecia areata
- Baricitinib in Alopecia Areata: Real-Life Changes in Lipid Profile and Hematologic Inflammation Indices at 52 weeks
- Systematic review and indirect treatment comparisons of ritlecitinib against baricitinib in alopecia areata
- Baricitinib maintains regrowth of hair, eyebrows, and eyelashes over 3 years
- 397 Predictive modeling of drug response and mechanism of action in alopecia areata clinical trials
- Oral Tofacitinib in Refractory Pediatric Alopecia Areata
- Surgical Approaches for Repigmenting Vitiligo 2.0
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Hair Loss in Lichen Planopilaris and Frontal Fibrosing Alopecia: Not Always Irreversible